NLSP
NLS Pharmaceutics Ltd. · NASDAQ
- Sector Health Technology
- Industry Pharmaceuticals: Major
- Website nlspharma.com
- Employees(FY) -
- ISIN CH0523961370
Performance
-0.79%
1W
-2.53%
1M
-70.07%
3M
-79.91%
6M
-76.5%
YTD
-89.66%
1Y
Profile
NLS Pharmaceutics AG, a clinical-stage biopharmaceutical company, engages in the discovery and development of therapies for patients with rare and complex central nervous system disorders. The company is focusing on the development of treatments for narcolepsy, idiopathic hypersomnia, and other rare sleep disorders, as well as neurodevelopmental disorders, such as attention deficit hyperactivity disorder (ADHD). Its lead product candidates include Quilience to treat excessive daytime sleepiness and cataplexy; and Nolazol for the treatment of ADHD. The company also developing NLS-4, a selective dopamine reuptake inhibitor to prevent rare sleep disorders; NLS-3, a repurposed reverse ester of methylphenidate for treatment of ADHD; NLS-8, a melatonin ML1A receptor agonist, improved scopolamine-induced amnesia; NLS-11, a norepinephrine and dopamine reuptake inhibitor and muscarinic M1, M2, M3 receptor antagonist; and NLS-12, a norepinephrine and dopamine reuptake inhibitor and muscarinic M4 receptor antagonist. NLS Pharmaceutics AG was incorporated in 2015 and is based in Zurich, Switzerland.
Technical Analysis of NLSP 2024-05-03
Overview:
In analyzing the technical indicators for NLSP stock over the last 5 days, we will delve into the trend, momentum, volatility, and volume indicators to provide a comprehensive outlook on the possible stock price movement in the coming days. By examining these key indicators, we aim to offer valuable insights and predictions for potenti...
Recent News & Updates
- 2024-04-19 05:00
- 2024-03-22 04:30
- 2024-03-20 01:40
- 2024-03-19 19:30
- 2024-03-13 20:00
- 2024-03-10 19:00
- 2024-02-22 18:30
- 2024-01-12 03:30
- 2023-12-29 03:30
NLS Pharmaceutics CEO Issues Letter to Shareholders(Yahoo Finance)
- 2023-12-03 20:06
Why Is NLS Pharmaceutics (NLSP) Stock Down 24% Today?(Investorplace)
- 2023-12-03 18:21
10 Best Debt Free Penny Stocks To Buy Now(Yahoo Finance)
- 2023-11-30 18:30
- 2023-11-27 18:30
- 2023-11-26 19:30
- 2023-11-15 19:00
- 2023-10-25 04:30
- 2023-10-19 05:00
- 2023-10-11 21:40
- 2023-08-27 19:30
NLS Pharmaceutics CEO Issues Letter to Shareholders(Yahoo Finance)
- 2023-07-02 19:00
- 2023-06-30 04:05
- 2023-06-29 20:00
NLS Pharmaceutics Company Update and Webcast Today Postponed(Yahoo Finance)
- 2023-06-18 19:30
- 2023-06-18 19:10
NLS Pharmaceutics Announces Company Update Webcast(Yahoo Finance)
- 2023-06-14 20:30
- 2023-06-14 19:30
NLS Pharmaceutics Announces Company Update Webcast(Yahoo Finance)
- 2023-06-13 19:30
- 2023-05-07 20:30
- 2023-05-03 20:30
- 2023-05-01 20:45
Page 1 of 4
previousnext